Complete Revascularisation Following Acute MI: A Contemporary Review
Related Experiment Video
Updated: May 6, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Ahmed Gonnah1, Nadhrah Darke1, Liam Mullen2
1School of Medicine, University of Liverpool Liverpool, UK.
Insights
Acute myocardial infarction (AMI) management requires timely reperfusion. Complete revascularization is favored in STEMI, but optimal strategies for NSTEMI with multivessel disease need further research.
Area of Science:
- Cardiology
- Interventional Cardiology
Background:
- Acute myocardial infarction (AMI) is a major global cause of death.
- Timely reperfusion is critical for minimizing adverse outcomes in AMI patients.
Purpose of the Study:
- To review current revascularization strategies for AMI, including ST-elevation MI (STEMI) and non-STEMI (NSTEMI) with multivessel disease.
- To identify uncertainties and gaps in knowledge regarding optimal treatment approaches, particularly for NSTEMI patients.
Main Methods:
- Review of evidence from randomized trials and observational studies on revascularization strategies.
- Analysis of current guidelines and their limitations for complex NSTEMI cases.
Main Results:
- Complete revascularization is strongly supported in STEMI.
- Limited data exists comparing immediate versus staged complete revascularization, and the role of physiology-guided vs. angiography-guided treatment remains uncertain.
- Current guidelines offer limited recommendations for NSTEMI patients with multivessel disease, highlighting the need for individualized treatment.
Conclusions:
- Optimal revascularization strategies for NSTEMI with multivessel disease require further investigation.
- Future trials should incorporate functional health status and quality of life outcomes to improve decision-making in AMI management.
Abstract:
Acute MI (AMI) is a leading cause of mortality globally. Swift diagnosis is imperative, with timely reperfusion crucial to minimise adverse outcomes. Revascularisation strategies include culprit-vessel-only therapy, staged complete revascularisation or immediate complete revascularisation. Evidence from randomised trials strongly favours complete revascularisation in ST-elevation MI (STEMI). Data regarding immediate complete revascularisation compared to a staged approach are limited, with uncertainties regarding the advantages of physiology-guided treatment compared to angiographic assessment alone. Non-STEMI (NSTEMI) patients with multivessel disease are often complex and current guidelines offer limited recommendations for this patient group, emphasising the need for individualised treatment. Observational studies have sought to find the optimal approach, yet conflicting data prevails. Dedicated trials for this issue in NSTEMI patients are currently unavailable. To enhance the decision-making processes for patients with AMI, future trials should consider the inclusion of functional health status and health-related quality of life outcomes. The existing gaps in knowledge underscore the intricacies of managing AMI and the ongoing necessity for comprehensive research to refine treatment strategies.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Angina IV: Management